These include inducing apoptosis specifically in cancer cells via CB2R activation, inhibiting cell proliferation through pathways like PI3 K/AKT and MAPK, reducing angiogenesis to limit tumor growth, modulating the tumor microenvironment to enhance immune detection, and lowering inflammation associated with cancer progression. This evidence concerns the gene AKT1 and neoplasm.